publication venue for Penicillin-Binding Proteins and Alternative Dual-Beta-Lactam Combinations for Serious Enterococcus faecalis Infections with Elevated Penicillin MICs. 67. 2023 Meropenem plus Ceftaroline Is Active against Enterococcus faecalis in an In Vitro Pharmacodynamic Model Using Humanized Dosing Simulations. 66. 2022 First-Time-in-Human Study and Prediction of Early Bactericidal Activity for GSK3036656, a Potent Leucyl-tRNA Synthetase Inhibitor for Tuberculosis Treatment. 63. 2019 Discovery of novel oral protein synthesis inhibitors of mycobacterium tuberculosis that target leucyl-tRNA synthetase. 60:6271-6280. 2016 Linking murine and human Plasmodium falciparum challenge models in a translational path for antimalarial drug development. 60:3669-3675. 2016 Homologous recombination within large chromosomal regions facilitates acquisition of ß-lactam and vancomycin resistance in Enterococcus faecium. 60:5777-5786. 2016 Development of an intracellular screen for new compounds able to inhibit Mycobacterium tuberculosis growth in human macrophages. 60:640-645. 2015 Mycobacterium tuberculosis gyrase inhibitors as a new class of antitubercular drugs. 59. 2015 Histone methyltransferase inhibitors are orally bioavailable, fast-acting molecules with activity against different species causing malaria in humans. 59:950-959. 2015 Streptomycin-starved Mycobacterium tuberculosis 18b, a drug discovery tool for latent tuberculosis. 56. 2012 Aminoindoles, a Novel Scaffold with Potent Activity against Plasmodium falciparum. 55:2612-2622. 2011